Women’s health at FDA
This article was originally published in The Gray Sheet
Executive Summary
Drug center scientist Kathleen Uhl will become director of FDA's Office of Women's Health in mid-December, the agency announces Nov. 21. Theresa Toigo has served as acting head since Sept. 16 to fill a hole left by Susan Wood, who resigned in protest over the agency's handling of Barr's Plan B emergency contraceptive pill (1"The Gray Sheet" Sept. 5, 2005, p. 6)...